TD Cowen lowered its price target for Beauty Health, while Invesco and Rhumbline increased their holdings in the stock.
3 reports, 1 independent
Updated Thu 00:00
Still developing
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
TD Cowen lowered its price target for Beauty Health, while Invesco and Rhumbline increased their holdings in the stock.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.TD Cowen initiates coverage of Beauty Health.1 source
TD Cowen lowered price target for Beauty Health; Invesco and Rhumbline increased positions.1 source
Keep exploring
The entities involved
-
TD Cowen
American investment bank
Related events
- TD Cowen boosted its price target and gave a buy rating for Jazz Pharmaceuticals.
- TD Cowen raised its price target for HCA Healthcare, Inc. on October 23, 2026.
- TD Cowen lowered its price target for Ceva shares on November 2, 2026.
- Truist Financial set a $90.00 price target on Edwards Lifesciences shares, and TD Cowen reaffirmed its buy rating and raised the price objective.
- TD Cowen and Bank of America issued buy ratings and increased price targets on November 2, 2026.